MedPath

A clinical trial to study the efficacy of matrabasti in insomnia

Phase 2
Registration Number
CTRI/2020/11/029277
Lead Sponsor
Amruta Arjun Chavare
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient already diagnosed for primary insomnia by APA2000 diagnostic criteria

•Patient who are suffering from the signs and symptoms of anidra and willing for treatment.

•Subjects from either sex will be selected.

•Patients between 40-60 years age group.

•Subjects will be selected irrespective of socioeconomic conditions

•Patient complaining of reduction in sleep time, difficulty in initiation of sleep, unsatisfactory sleep and disturbed sleep either any of these or all of these.

Exclusion Criteria

Patients suffering from anidra due to other conditions like madatyaya and abhighata

Patients suffering from anidra associated with other systemic and metabolic disorders like renal diseases cardiac diseases / endocrinal diseases / tuberculosis.

•Insomnia due to addiction

•Insomnia due to severe psychic disorder

•Lactating women

•Pregnant women

•Uncontrolled Diabetes Mellitus and Hypertension.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Induction of normal sleep in patients having primary insomnia and reduction of score of Athense Insomnia Scale and Insomnia Severity Index scaleTimepoint: Assesment on 0,3,5,7 th day and follow up on 15 th day
Secondary Outcome Measures
NameTimeMethod
Induction of normal sleep in patients having primary insomniaTimepoint: 7 days
© Copyright 2025. All Rights Reserved by MedPath